| Literature DB >> 24787297 |
Elisabeth A Seftor1, Richard E B Seftor1, Don Weldon2, Gina T Kirsammer1, Naira V Margaryan1, Alina Gilgur1, Mary J C Hendrix1.
Abstract
As the frequency of melanoma increases, current treatment strategies are struggling to significantly impact patient survival. One of the critical issues in designing efficient therapies is understanding the composition of heterogeneous melanoma tumors in order to target cancer stem cells (CSCs) and drug-resistant subpopulations. In this review, we summarize recent findings pertinent to the reemergence of the embryonic Nodal signaling pathway in melanoma and its significance as a prognostic biomarker and therapeutic target. In addition, we offer a novel molecular approach to studying the functional relevance of Nodal-expressing subpopulations and their CSC phenotype.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24787297 PMCID: PMC4026856 DOI: 10.1053/j.seminoncol.2014.02.001
Source DB: PubMed Journal: Semin Oncol ISSN: 0093-7754 Impact factor: 4.929